• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于平面测量法对费城染色体阴性慢性骨髓增殖性疾病中巨核细胞组织学图片进行客观评估:一种有价值辅助诊断工具的前景

Objective, planimetry-based assessment of megakaryocyte histological pictures in Philadelphia-chromosome-negative chronic myeloproliferative disorders: a perspective for a valuable adjunct diagnostic tool.

作者信息

Rudzki Zbigniew, Kawa Rafał, Okoñ Krzysztof, Szczygieł Ewa, Stachura Jerzy

机构信息

Department of Pathomorphology, Collegium Medicum, Jagiellonian University, Grzegórzecka 16, 31-531 Cracow, Poland.

出版信息

Virchows Arch. 2006 Jan;448(1):59-67. doi: 10.1007/s00428-005-0077-1. Epub 2005 Oct 12.

DOI:10.1007/s00428-005-0077-1
PMID:16220296
Abstract

Philadelphia-chromosome-negative chronic myeloproliferative disorders (Ph- CMPDs)--essential thrombocythemia (ET), chronic idiopathic myelofibrosis (CIMF), and polycythemia vera (PV)--may show clinical and morphological similarities, particularly at the early stages. The differential diagnosis of Ph- CMPDs is important due to their different treatment and prognosis. Cytological features of megakaryocytes are considered valuable in this differentiation. To establish an objective measure of megakaryocyte dysplasia in Ph- CMPDs, we performed computer-assisted morphometry of more than 4,000 cells from 20 cases of ET, 10 of CIMF, 10 of PV, and 10 controls. Megakaryocyte sets from three Ph- CMPDs differed significantly in respect to many planimetric parameters, but not a single shape or size parameter could have been used as a discriminative tool between the entities. However, the discriminant function analysis with the simultaneous assessment of 12 planimetric variables allowed for a proper classification of 20 of 20 ET, 10 of 10 PV, and 9 of 10 CIMF cases based solely on the morphometric features of megakaryocytes. Additionally, we identified certain new patterns of megakaryocytes specific for ET, PV, and CIMF, which, although not dominating in one Ph- CMPD, are unlikely to occur in two others. Objective measurements of megakaryocyte sizes and shapes may assist the diagnosis of Ph- CMPDs.

摘要

费城染色体阴性慢性骨髓增殖性疾病(Ph- CMPDs)——原发性血小板增多症(ET)、慢性特发性骨髓纤维化(CIMF)和真性红细胞增多症(PV)——可能表现出临床和形态学上的相似性,尤其是在疾病早期。由于它们的治疗方法和预后不同,因此对Ph- CMPDs进行鉴别诊断很重要。巨核细胞的细胞学特征在这种鉴别中被认为是有价值的。为了建立一种客观衡量Ph- CMPDs中巨核细胞发育异常的方法,我们对来自20例ET、10例CIMF、10例PV和10例对照的4000多个细胞进行了计算机辅助形态测量。来自三种Ph- CMPDs的巨核细胞集在许多平面测量参数方面存在显著差异,但没有一个形状或大小参数可以用作区分这些疾病实体的工具。然而,通过同时评估12个平面测量变量进行判别函数分析,仅根据巨核细胞的形态特征就可以对20例ET中的20例、10例PV中的10例和10例CIMF中的9例进行正确分类。此外,我们还发现了某些特定于ET、PV和CIMF的巨核细胞新模式,这些模式虽然在一种Ph- CMPD中不占主导,但在其他两种中不太可能出现。巨核细胞大小和形状的客观测量可能有助于Ph- CMPDs的诊断。

相似文献

1
Objective, planimetry-based assessment of megakaryocyte histological pictures in Philadelphia-chromosome-negative chronic myeloproliferative disorders: a perspective for a valuable adjunct diagnostic tool.基于平面测量法对费城染色体阴性慢性骨髓增殖性疾病中巨核细胞组织学图片进行客观评估:一种有价值辅助诊断工具的前景
Virchows Arch. 2006 Jan;448(1):59-67. doi: 10.1007/s00428-005-0077-1. Epub 2005 Oct 12.
2
Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).慢性骨髓增殖性疾病(MPD)、原发性血小板增多症(ET)、真性红细胞增多症(PV)和慢性特发性骨髓纤维化(CIMF)的现行诊断标准。
Pathol Biol (Paris). 2007 Mar;55(2):92-104. doi: 10.1016/j.patbio.2006.06.002. Epub 2006 Aug 21.
3
Different involvement of the megakaryocytic lineage by the JAK2 V617F mutation in Polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis.真性红细胞增多症、原发性血小板增多症和慢性特发性骨髓纤维化中JAK2 V617F突变对巨核细胞系的不同影响。
Ann Hematol. 2007 Apr;86(4):245-53. doi: 10.1007/s00277-007-0252-3. Epub 2007 Jan 30.
4
Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.骨髓增殖性疾病(原发性血小板增多症、真性红细胞增多症、原发性巨核细胞粒细胞化生及骨髓纤维化)的诊断、发病机制与治疗
Neth J Med. 1999 Feb;54(2):46-62. doi: 10.1016/s0300-2977(98)00143-0.
5
Histological and molecular classification of chronic myeloproliferative disorders in the age of JAK2: persistence of old questions despite new answers.JAK2时代慢性骨髓增殖性疾病的组织学和分子分类:尽管有了新答案,但老问题依然存在。
Pathobiology. 2007;74(2):72-80. doi: 10.1159/000099120.
6
Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).原发性血小板增多症、真性红细胞增多症和原发性骨髓纤维化(特发性髓样化生)诊断的临床及病理标准。
Int J Hematol. 2002 Aug;76(2):133-45. doi: 10.1007/BF02982575.
7
Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoietic bone marrow histology.原发性血小板增多症还是慢性特发性骨髓纤维化?一项基于造血骨髓组织学的单中心研究。
Leuk Lymphoma. 2006 Sep;47(9):1774-81. doi: 10.1080/10428190600678975.
8
Diagnostic criteria of the myeloproliferative disorders (MPD): essential thrombocythaemia, polycythaemia vera and chronic megakaryocytic granulocytic metaplasia.骨髓增殖性疾病(MPD)的诊断标准:原发性血小板增多症、真性红细胞增多症和慢性巨核细胞粒细胞化生。
Neth J Med. 1997 Aug;51(2):57-64. doi: 10.1016/s0300-2977(97)00018-1.
9
Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.真性红细胞增多症、原发性血小板增多症以及原发性骨髓纤维化伴或不伴JAK2 V617F突变时的巨核细胞形态及临床参数
Arch Pathol Lab Med. 2014 Sep;138(9):1203-9. doi: 10.5858/arpa.2013-0018-OA.
10
Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.真性红细胞增多症研究组关于修订原发性血小板增多症和真性红细胞增多症诊断标准的提议。
Semin Thromb Hemost. 1997;23(4):339-47. doi: 10.1055/s-2007-996107.

本文引用的文献

1
Value of bone marrow biopsy in the diagnosis of essential thrombocythemia.骨髓活检在原发性血小板增多症诊断中的价值。
Haematologica. 2004 Aug;89(8):911-9.
2
Deciding on transplantation for myelofibrosis: setting the record straight.骨髓纤维化的移植决策:澄清事实
Mayo Clin Proc. 2004 Jul;79(7):953-4. doi: 10.4065/79.7.953.
3
Chronic myeloproliferative diseases on a pathologist's desk--a dilemma of distinct entities versus a clinico-pathologic continuum. A descriptive study based on a material from the Polish population.
病理学家桌上的慢性骨髓增殖性疾病——截然不同的实体与临床病理连续统一体的困境。一项基于波兰人群材料的描述性研究。
Pol J Pathol. 2004;55(1):13-23.
4
Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia.骨髓组织病理学和生物学标志物作为原发性血小板增多症、真性红细胞增多症以及纤维化前期或纤维化无明确病因的骨髓化生鉴别诊断的特异性线索。
Hematol J. 2004;5(2):93-102. doi: 10.1038/sj.thj.6200368.
5
Stem cell transplantation for myelofibrosis: a report from two Canadian centers.骨髓纤维化的干细胞移植:来自加拿大两个中心的报告。
Bone Marrow Transplant. 2003 Jul;32(1):35-40. doi: 10.1038/sj.bmt.1704075.
6
Histomorphometric study of megakaryocytes in bone marrow in selected myeloproliferative and lymphoproliferative diseases.特定骨髓增殖性疾病和淋巴细胞增殖性疾病中骨髓巨核细胞的组织形态计量学研究
Folia Morphol (Warsz). 2003 Feb;62(1):51-6.
7
Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients.伴有血小板增多症的慢性骨髓增殖性疾病:对839例患者的两种分类系统(PVSG、WHO)的比较研究
Ann Hematol. 2003 Mar;82(3):148-52. doi: 10.1007/s00277-002-0604-y. Epub 2003 Feb 22.
8
Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).原发性血小板增多症、真性红细胞增多症和原发性骨髓纤维化(特发性髓样化生)诊断的临床及病理标准。
Int J Hematol. 2002 Aug;76(2):133-45. doi: 10.1007/BF02982575.
9
Myeloproliferative disorders: complications, survival and causes of death.骨髓增殖性疾病:并发症、生存率及死亡原因
Ann Hematol. 2000 Jun;79(6):312-8. doi: 10.1007/s002779900136.
10
Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity.真性红细胞增多症、慢性粒细胞白血病和骨髓纤维化时的骨髓血管增多。
Am J Pathol. 2000 Jul;157(1):15-9. doi: 10.1016/S0002-9440(10)64511-7.